Focus: Tissium is a France-based medical device biotech specializing in synthetic polymers for vascular sealing and surgical repair, with a focus on cardiovascular, nerve, and hernia repair applications. The company is publicly listed and recently secured €60M in funding to advance its sutureless nerve repair platform.
Profile data last refreshed 2h ago · AI intelligence enriched 3w ago
Best fit for early-career or mission-driven professionals seeking direct impact in surgical innovation with acceptable regulatory and financial risk, but not for those requiring large-scale organizational resources or near-term commercial scale.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Tissium
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Tissium's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Tissium wins €60m to bring sutureless nerve repair system to market - Medical Device Network
Tissium wins €60m to bring sutureless nerve repair system to market Medical Device Network
Member News June 2026 - The American College of Surgeons
Member News June 2026 The American College of Surgeons
Based on last 4 crawl cycles
Recent peer-reviewed publications with author affiliations at this company
Showing 5 of 7 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo